Levels of IGFBP-1, MMP-9 and circulating nucleosomes: a new model to diagnose SSc-ILD

J. Guiot (Liège, Belgium), M. Henket (Liège, Belgium), B. André (Liège, Belgium), N. Hardat (Namur, Belgium), M. Herzog (Namur, Belgium), M. Njock (Liège, Belgium), M. Malaise (Liège, Belgium), R. Louis (Liège, Belgium)

Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Guiot (Liège, Belgium), M. Henket (Liège, Belgium), B. André (Liège, Belgium), N. Hardat (Namur, Belgium), M. Herzog (Namur, Belgium), M. Njock (Liège, Belgium), M. Malaise (Liège, Belgium), R. Louis (Liège, Belgium). Levels of IGFBP-1, MMP-9 and circulating nucleosomes: a new model to diagnose SSc-ILD. 798

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Are there serum levels of MMP-2 and MMP-9 may be markers of COPD phenotypes?
Source: Annual Congress 2012 - COPD treatment and varia
Year: 2012

Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease?
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006

Significance of serum YKL-40, S100A8, S100A9, calprotectin, periostin and LRG1 levels in patients with newly diagnosed, controlled and uncontrolled asthma
Source: International Congress 2018 – Clinical determinants and biomarkers of COPD
Year: 2018

Serum levels of TIMP-1 and TIMP-2 are elevated in patients with pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 463s
Year: 2003

YKL-40, soluble IL-2 receptor, ADA and neopterin: comparison of markers of sarcoidosis activity
Source: Annual Congress 2009 - Sarcoidosis in review
Year: 2009

Increased serum levels of LL37, HMGB1 and S100A9 during exacerbation in COPD patients
Source: Eur Respir J 2015; 45: 1482-1485
Year: 2015

Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017

Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018

Evaluation of CCL18 serum levels and genetic variant as prognostic biomarkers in SSc-ILD
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021

Circulating matrix metalloproteinase-9 (MMP-9) is associated with the extension of lung disease in patients with active tuberculosis
Source: Eur Respir J 2004; 24: Suppl. 48, 35s
Year: 2004

Circulating eNAMPT and resistin as emerging biomarkers in sepsis
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018

High serum levels of YKL-40 in IPF
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008

Characterisation of asthma subgroups associated with circulating YKL-40 levels
Source: Eur Respir J, 50 (4) 1700800; 10.1183/13993003.00800-2017
Year: 2017

TNF-alpha, IL-8, IL-6 levels in serum of sarcoidosis patients with different clinical course
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013

Elevated serum S100A4 levels in patients with silicosis
Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Year: 2019

Increased EMMPRIN and MT1-MMP levels in the plasma of the stable adult patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 404s
Year: 2005

Plasma levels of TIPM-2 in patients with COPD
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016

Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages
Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Year: 2020

Determinants of serum leptin and adiponectin levels in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005

PP231 – Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF
Source: ERS Lung Science Conference 2021
Year: 2021